- Home
- JRSH vs GNTA Comparison
JRSH vs GNTA Comparison
Compare JRSH & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JRSH | GNTA |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1M | 34.0M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | JRSH | GNTA |
|---|---|---|
| Price | $3.20 | $0.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 70.3K | ★ 110.8K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.27% | N/A |
| EPS Growth | ★ 56.25 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $145,812,006.00 | N/A |
| Revenue This Year | $11.64 | N/A |
| Revenue Next Year | $10.06 | N/A |
| P/E Ratio | $21.33 | ★ N/A |
| Revenue Growth | ★ 24.43 | N/A |
| 52 Week Low | $2.81 | $0.71 |
| 52 Week High | $3.70 | $10.00 |
Technical Indicators
Market Signals| Indicator | JRSH | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 40.85 |
| Support Level | $3.03 | $0.71 |
| Resistance Level | $3.52 | $1.70 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 18.77 | 35.87 |
Price Performance
Historical ComparisonAbout JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.